CNS Pharmaceuticals holds annual meeting, shareholders expand equity plan
Stockholders approved a 650,000-share increase to the company's 2020 Equity Plan and re-elected all six director nominees at the September 30, 2026 annual meeting.
SEC filing
Latest
1 story